Jazz Pharma - JAZZ Net earnings per share growth forecast for next year

Corporate company logo of Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals is expanding its portfolio of innovative formulas through partnerships with biotech startups in neurology and oncology. The brand's high authority is confirmed by physician trust in its medications for treating rare sleep pathologies. The company is currently integrating acquired cannabinoid assets, temporarily limiting new M&A deals. The consensus on next year's earnings per share reflects financial stability, with the metric value standing at 78.20.

Jazz Pharma (JAZZ): Net earnings per share growth forecast for next year from 07/04/2022 to 11/16/2026

Summary analytical data breakdowns for Jazz Pharma (JAZZ)

Fundamental company analysis:JAZZ, Jazz Pharma
Finished products of Jazz Pharmaceuticals PLC

This indicator reflects the aggregate analyst expectations for earnings per share growth rates, measuring future business efficiency through the lens of consensus forecasts. The positive trend in the consensus estimate for net profit growth confirms the resilience of the Jazz Pharmaceuticals (JAZZ) model, where large-scale robotization of drug packaging and filling is expected to reduce operating expenses, directly converting into accelerated margin growth.

Direct competitors

Net earnings per share growth forecast for next year Cytokinetics|PTCT: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Scholar Rock Inc. (SRRK)|CNTA - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year dyne-tx.com DYN|Edgewise Corp - Net earnings per share growth forecast for next year|RAPP - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Alumis Inc.|ZVRA: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Contineum Pharma CTNM|Expected earnings per share growth for next year LRMR|Expected net earnings per share growth next year Capricor Therapeutics CAPR|Earnings growth forecast for next year TRDA|Expected earnings per share growth for next year Channel Therapeutics PTHS|Earnings growth forecast for next year MNOV (MediciNova)|Expected earnings per share trend next year SER|BTAI - Net earnings per share growth forecast for next year|promisneurosciences.com (PMN) - Expected earnings per share growth for next year|Apimeds (APUS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AEON|Net earnings per share growth forecast for next year NLS Pharma|Expected net earnings per share growth next year bionomics.com.au BNOX|Earnings growth forecast for next year HUGE|RETA (Reata Pharma) - Expected earnings per share trend next year